Next Article in Journal
Significance of Bioconvective and Thermally Dissipation Flow of Viscoelastic Nanoparticles with Activation Energy Features: Novel Biofuels Significance
Previous Article in Journal
Applying Educational Data Mining to Explore Students’ Learning Patterns in the Flipped Learning Approach for Coding Education
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Symmetry
Volume 12
Issue 2
10.3390/sym12020215
symmetry-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preparation of Enantiomerically Enriched P-Stereogenic Dialkyl-Arylphosphine Oxides via Coordination Mediated Optical Resolution

by
Bence Varga
and
Péter Bagi
*
Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Műegyetem rkp. 3., H-1111 Budapest, Hungary
*
Author to whom correspondence should be addressed.
Symmetry 2020, 12(2), 215; https://doi.org/10.3390/sym12020215
Submission received: 12 December 2019 / Revised: 10 January 2020 / Accepted: 14 January 2020 / Published: 2 February 2020
(This article belongs to the Section Chemistry: Symmetry/Asymmetry)
Browse Figures
Versions Notes

Abstract

:
Optical resolution of several dialkyl-arylphosphine oxides was elaborated using the Ca2+ salt of (−)-O,O’-dibenzoyl-(2R,3R)-tartaric acid as the resolving agent. The conditions of crystallization and purification of the enantiomerically enriched phosphine oxides were optimized. Ethyl-phenyl-propylphosphine oxide and butyl-methyl-phenylphosphine oxide were prepared with an enantiomeric excess higher than 93%, whereas, three other dialkyl-arylphosphine oxides were obtained with an enantiomeric excess of 37–85%. It was also found that the sterically demanding alkyl chains hinder the formation of stable diastereomeric complexes, which consequently led to less efficient resolution procedures.

Graphical Abstract

1. Introduction

Chiral compounds form an important class in organophosphorus chemistry. These species may contain an asymmetric element either on the phosphorus atom or at other parts of the molecular scaffold [1,2,3]. Chiral organophosphourus compounds were traditionally used as ligands in transition metal-catalyzed transformations [4,5]. In the past two decades, application of phosphines [6,7,8], phosphine oxides [9,10] or phosphonium salts [11,12] as enantioselective organocatalysts became an emerging area. Many enantioselective (organo)catalytic transformations take place in the close proximity of the phosphorus atom, which signifies the application of the corresponding P-stereogenic species [13].
Methods developed for the preparation of P-chiral compounds include stereoselective syntheses from racemic or prochiral starting materials using chiral catalysts [14,15] or auxiliaries [16,17,18,19,20,21,22,23,24], stereospecific transformations of secondary phosphine oxides or phosphinates [16,25,26,27,28], as well as kinetic [29,30,31,32,33], dynamic kinetic [34,35,36,37,38], chromatographic [39,40] or classical resolutions [41,42,43,44,45,46]. Classical resolutions are generally robust, bench-stable processes that can be scaled up. Moreover, resolving agents can be recycled, and the undesired enantiomer can be racemized and reused [47,48]. One group of resolution methods developed for chiral phosphine oxides applies classical resolving agents having either acidic or basic character. However, this strategy requires the presence of basic or acidic functional groups in the racemic P-derivative [49]. Other resolution strategies rely on interactions between the P = O group of a phosphine oxide and the H-bond donor functional groups of the resolving agent. BINOL [41], TADDOL- [44,45], camphorsulfonic acid- [50], mandelic acid- [42] or tartaric acid derivatives [37,43] were used for the optical resolution of P-stereogenic phosphine oxides. BINOL and TADDOL-derivatives are relatively expensive, whereas optical resolutions with chiral acids had a rather limited scope. Another resolution method may involve a combination of the enantiomeric recognition ability of a chiral resolving agent, and the coordination ability of a metal ion. In this manner, good enantiomeric separation could be achieved, even with cheap resolving agents. This coordination mediated resolution technique was used to separate the enantiomers of chiral alcohols, hydroxy- or halo carboxylic acids [51,52,53,54,55]. Moreover, Ca2+- and Mg2+-salts of tartaric acid derivatives were suitable resolving agents for the preparation of several five- and six-membered P-heterocycles in optically active form [44], and our research group published one example for the enantiomeric separation, an acyclic diaryl-alkylphoshophine oxide [45]. Antipodes Tenofovir Alafenamide could also be separated using a coordination mediated resolution. It indicates that resolution procedures have high value for biologically active organophosphorus compounds, as well [56].
In this paper, the optical resolution of a series of dialkyl-phenylphosphine oxides was studied. For this compound class, only one resolution method applying BINOL was reported. Thus, our aim was to investigate, whether the significantly cheaper metal salts of tartaric acid derivatives can be used for the optical resolution of the selected acyclic phosphine oxides, as seen in Figure 1.

2. Materials and Methods

2.1. General

The details of chemicals, instruments used in this study, a few synthetic procedures, as well as the characterization of optically active P-oxides (1–7) can be found in the Supplementary Material.

2.2. Resolution of Ethyl-Phenyl-Propylphosphine Oxide (3) with in Situ Prepared Resolving Agents (Representative Procedure)

In total, 0.096 g (0.26 mmol) of DBTA·H2O and 7.1 mg (0.13 mmol) of CaO were refluxed in 0.31 mL of ethanol and 31 µL of water until it became clear. To this solution of in situ formed Ca(H-DBTA)2 [(R,R)-8], 0.050 g (0.26 mmol) of racemic ethyl-phenyl-propylphosphine oxide (3) in 0.31 mL of hot ethyl acetate was added. Colorless crystalline diastereomeric complex of (S)-3·Ca(H-DBTA)2 appeared after cooling the mixture to 25 °C. After standing at 25 °C for 24 h, the crystals were separated by filtration, washed with a mixture of 0.10 mL of ethanol and 0.10 mL of ethyl acetate, to give 0.075 g (62%) of (S)-3·Ca(H-DBTA)2 with a de of 69% (Table 1, Entry 2).
Resolution of racemic phosphine oxides (1–7) was performed according to this representative procedure when the following resolving agents were used: Ca(H-DBTA)2 [(R,R)-8], Ca(H-DPTTA)2 [(R,R)-9], Ca(DBTA) [(R,R)-10] and Ca(DPTTA) [(R,R)-11]. Conditions and results are shown in Table 1, Entries 3–5, and in Table 2.
When Ca(DBTA) [(R,R)-10] or Ca(DPTTA) [(R,R)-11] was the resolving agent, the molar ratio of DBTA·H2O or DPTTA·H2O and CaO was 1:1 (Table 1, Entries 3 and 5). When resolutions were carried out according to the equivalent method, the amount of DBTA·H2O and CaO was doubled (Table 2, Entries 10–16).
When different solvent mixtures were used for resolution, the resolving agent [(R,R)-8] was prepared in situ in the corresponding alcohol and water, and phosphine oxide 3 was added in the other component of the solvent mixture. When only ethyl acetate was the solvent, diastereomeric complex (S)-3·Ca(H-DBTA)2 was prepared, as described above. Then the solvent was evaporated under reduced pressure, and diastereomer (S)-3·Ca(H-DBTA)2 was re-dissolved in boiling ethyl acetate. Crystallization and isolation of the diastereomer were carried out according to the representative procedure described above (Table 2, Entry 9).

2.3. Purification of Diastereomeric Complex of (S)-3·Ca(H-DBTA)2

In total, 0.30 g (0.32 mmol) of (S)-3·Ca(H-DBTA)2 with a de of 74% [prepared from 0.16 g (0.80 mmol) of racemic ethyl-phenyl-propylphosphine oxide (3), 0.61 g (1.61 mmol) of DBTA·H2O and 0.045 g (0.80 mmol) of CaO in 1.95 mL of ethanol, 0.20 mL of water and 1.95 mL of ethyl acetate according to Representative Procedure (Table 2, Entry 10)] was divided into 3 equal parts.

2.3.1. Purification of Diastereomeric Complex of (S)-3·Ca(H-DBTA)2 by Digestion (Purification Method I)

0.10 g (0.11 mmol) of (S)-3·Ca(H-DBTA)2 with a de of 74% was stirred in a mixture of 0.65 mL of ethanol and 0.65 mL of ethyl acetate at 25°C for 24 h. The crystals were then separated by filtration, washed with 0.22 mL of ethanol and 0.22 mL of ethyl acetate, to give 0.061 g (47%) of (S)-3·Ca(H-DBTA)2 with a de of 77% (Scheme 3/II).

2.3.2. Purification of Diastereomeric Complex of (S)-3·Ca(H-DBTA)2 by Recrystallization (Purification Method II)

0.10 g (0.11 mmol) of (S)-3·Ca(H-DBTA)2 with a de of 74% refluxed for 5 min in a mixture of 0.65 mL of ethanol and 0.65 mL of ethyl acetate. Colorless crystalline diastereomeric complex of (S)-3·Ca(H-DBTA)2 appeared after cooling the mixture to 25°C. After standing at 25 °C for 24 h, the crystals were separated by filtration, washed with 0.22 mL of ethanol and 0.22 mL of ethyl acetate, to give 0.056 g (43%) of (S)-3·Ca(H-DBTA)2 with a de of 94% (Scheme 3/III).

2.3.3. Purification of Diastereomeric Complex of (S)-3·Ca(H-DBTA)2 by Repeated Resolution (Purification Method III)

0.10 g (0.11 mmol) of (S)-3·Ca(H-DBTA)2 with a de of 74% was decomposed by extraction using 10% aqueous ammonia (2 mL) and extracted with dichloromethane (3 × 2 mL). The organic layers were combined, dried (Na2SO4) and evaporated. The 0.020 g (0.10 mmol, 76%) of (S)-ethyl-phenyl-propyphosphine oxide [(S)-3] with an ee of 74% was resolved with 0.077 g (0.20 mmol) of DBTA·H2O and 5.7 mg (0.10 mmol) of CaO according to Representative Procedure, to give 0.062 g (48%) of (S)-3·Ca(H-DBTA)2 with a de of 93% (Scheme 3/IV and V).

2.4. Resolution of Dialkyl-Arylphosphine Oxides (1, 2, 4–7) with Ca(H-DBTA)2 [(R,R)-8]

In total, 0.75 mmol of phosphine oxide 1, 2 and 4-7 (1: 0.13 g, 2: 0.14 g, 4: 0.15 g, 5: 0.14 g, 6: 0.17 g and 7: 0.15 g) was resolved with Ca(H-DBTA)2 [(R,R)-8] according to Representative Procedure detailed in Section 2.2. The exact amounts of resolving agents and solvents are as follows. Phosphine oxide 1 and 7: 0.38 mmol of Ca(H-DBTA)2 (0.28 g of DBTA·H2O, 0.021 g CaO, 0.91 mL of EtOH, 91 µL of H2O, 0.91 mL of EtOAc); phosphine oxide 5: 0.50 mmol of Ca(H-DBTA)2 (0.38 g of DBTA·H2O, 0.028 g of CaO, 1.22 mL of EtOH, 0.12 µL of H2O, 1.22 mL of EtOAc); phosphine oxide 2, 4 and 6: 0.75 mmol of Ca(H-DBTA)2 (0.56 g of DBTA·H2O, 0.042 g of CaO, 1.82 mL of EtOH, 0.18 µL of H2O, 1.82 mL of EtOAc). The following diastereomeric complexes were prepared: 0.22 g (109%) of [(R)-1]2·Ca(H-DBTA)2 with a de of 34%; 0.056 g (16%) of (S)-2·Ca(H-DBTA)2 with a de of 37%; 0.093 g (26%) of (S)-4·Ca(H-DBTA)2 with a de of 75%; 0.23 g (91%) of [(R)-5]3·Ca2(H-DBTA)4 with a de of 32%; and 0.27 g (125%) of [(R)-7]2·Ca(H-DBTA)2 with a de of 3%. No diastereomeric complex formed in case of phosphine oxide 6.
The diastereomeric complexes incorporating phosphine oxide 1, 4, 5 or 7 were decomposed using 10% aqueous ammonia and dichloromethane according to procedure described in Section 2.3.3 to give 0.067 g (106%) of (R)-1 with an ee of 34%; 0.018 g (25%) of (S)-4 with an ee of 75%; 0.060 g (88%) of (R)-5 with an ee of 32%; 0.090 g (122%) of (R)-7 with an ee of 3%.
The resulting enantiomeric mixtures of phosphine oxide 1, 4, 5 or 7 were resolved with Ca(H-DBTA)2 [(R,R)-8] according to Representative Procedure detailed in Section 2.2 [phosphine oxide 1: 0.20 mmol of Ca(H-DBTA)2 (0.15 g of DBTA·H2O, 0.011 g CaO, 0.48 mL of EtOH, 48 µL of H2O, 0.48 mL of EtOAc); phosphine oxide 4: 0.094 mmol of Ca(H-DBTA)2 (0.071 g of DBTA·H2O, 5.3 mg of CaO, 0.23 mL of EtOH, 23 µL of H2O, 0.23 mL of EtOAc); phosphine oxide 5: 0.22 mmol of Ca(H-DBTA)2 (0.17 g of DBTA·H2O, 0.012 g of CaO, 0.53 mL of EtOH, 53 µL of H2O, 0.53 mL of EtOAc); phosphine oxide 7: 0.23 mmol of Ca(H-DBTA)2 (0.17 g of DBTA·H2O, 0.013 g of CaO, 0.56 mL of EtOH, 56 µL of H2O, 0.56 mL of EtOAc)] to give 0.15 g (73%) of [(R)-1]2·Ca(H-DBTA)2 with a de of 66%; 0.028 g (8%) of (S)-4·Ca(H-DBTA)2 with a de of 96%; 0.14 g (54%) of [(R)-5]3·Ca2(H-DBTA)4 with a de of 53%; 0.17 g (79%) of [(R)-7]2·Ca(H-DBTA)2 with a de of 3%.
The diastereomeric complexes incorporating phosphine oxide 1 or 5 were decomposed using 10% aqueous ammonia and dichloromethane according to procedures described in Section 2.3.3 to give 0.044 g (70%) of (R)-1 with an ee of 66%; 0.035 g (51%) of (R)-5 with an ee of 53%. The resulting enantiomeric mixtures of phosphine oxide 1 or 5 were resolved with Ca(H-DBTA)2 [(R,R)-8] according to Representative Procedure detailed in Section 2.2 [phosphine oxide 1: 0.13 mmol of Ca(H-DBTA)2 (0.10 g of DBTA·H2O, 7.4 mg CaO, 0.32 mL of EtOH, 32 µL of H2O, 0.32 mL of EtOAc); phosphine oxide 5: 0.13 mmol of Ca(H-DBTA)2 (0.096 g of DBTA·H2O, 7.1 mg of CaO, 0.31 mL of EtOH, 31 µL of H2O, 0.31 mL of EtOAc)] to give 0.093 g (46%) of [(R)-1]2·Ca(H-DBTA)2 with a de of 80%; 0.076 g (30%) of [(R)-5]3·Ca2(H-DBTA)4 with a de of 69%.
The diastereomeric complexes incorporating phosphine oxide 1 or 5 were decomposed using 10% aqueous ammonia and dichloromethane according to the procedure described in Section 2.3.3 to give 0.025 g (40%) of (R)-1 with an ee of 80%; 0.019 g (28%) of (R)-5 with an ee of 69%. The resulting enantiomeric mixtures of phosphine oxide 1 or 5 were resolved with Ca(H-DBTA)2 [(R,R)-8] according to Representative Procedure detailed in Section 2.2 [phosphine oxide 1: 0.075 mmol of Ca(H-DBTA)2 (0.056 g of DBTA·H2O, 4.2 mg CaO, 0.18 mL of EtOH, 18 µL of H2O, 0.18 mL of EtOAc); phosphine oxide 5: 0.070 mmol of Ca(H-DBTA)2 (0.053 g of DBTA·H2O, 3.9 mg of CaO, 0.17 mL of EtOH, 17 µL of H2O, 0.17 mL of EtOAc)] to give 0.065 g (32%) of [(R)-1]2·Ca(H-DBTA)2 with a de of 85%; 0.051 g (20%) of [(R)-5]3·Ca2(H-DBTA)4 with a de of 80%. The results are summarized in Table 3.

3. Results and Discussion

3.1. Optimization of Optical Resolution of Ethyl-Phenyl-Propylphosphine Oxide (3)

For optimizing the conditions of the optical resolution, ethyl-phenyl-propylphosphine oxide (3) was selected as model racemate, as it has an average size within the dialkyl-arylphosphine oxides (1–7) investigated in this study.
As coordination of the chiral tartaric acid scaffold and phosphine oxide to the cation is one of the most important interactions in the diastereomers formed, (−)-O,O′-dibenzoyl-(2R,3R)-tartaric acid was converted to its calcium-, magnesium-, copper-, nickel- or cobalt-salts to test which derivative is the most suitable for enantiomeric separation of ethyl-phenyl-propylphosphine oxide (3). Interestingly, only the acidic Ca2+-salt of (−)-O,O′-dibenzoyl-(2R,3R)-tartaric acid [(R,R)-8] led to the formation of crystalline diastereomers, and to partial enantiomeric separation of phosphine oxide 3 (ee: 44%, yield 83%). Using other metal salts, no crystals were formed, indicating that coordination of either tartaric acid or phosphine oxide (3) is low towards magnesium-, copper-, nickel- or cobalt (See Supplementary Material for details).
With the most suitable metal salt in hand, we started our optimization studies. The corresponding resolving agent [(R,R)-8–(R,R)-11] can either be prepared prior to reaction, or it can be formed in situ by reacting the given tartaric acid derivative with CaO in a mixture of ethanol and water. Besides (−)-O,O′-dibenzoyl-(2R,3R)-tartaric acid, (−)-O,O′-p-toluoyl-(2R,3R)-tartaric acid can also be used as chiral moiety. Moreover, Ca2+-salt of a given tartaric acid derivative can also be prepared in an acidic or neutral form [(R,R)-8–(R,R)-11], in which the ratio of Ca2+ and the given tartaric acid derivative is different. In our first few optimization experiments, we intended to select the most efficient resolution procedure, as well as the best tartaric acid derivative and its Ca2+-salt form [(R,R)-8–(R,R)-11] (Scheme 1). In the optimization experiments, results obtained after the first crystallization were evaluated and compared, and the diastereomeric complexes were not purified further. Composition of the given diastereomer was determined by 1H NMR, and enantiomeric excess of phosphine oxide 3 was measured by HPLC using a chiral stationary phase. Results are summarized in Table 1.
Results indicated, that higher enantiomeric excess and resolving capability values (i.e., higher efficiency) could be achieved when ethyl-phenyl-propylphosphine oxide (3) is resolved with Ca(H-DBTA)2 [(R,R)-8] prepared in situ, in contrary to the case when a pre-made resolving agent [(R,R)-8] is used (Table 1, Entries 1–2). Besides the difference in the experimental procedure, 10% of water used for in situ preparation of Ca(H-DBTA)2 may be another reason for the improved results.
Comparing different tartaric acid derivatives and their Ca2+-salts, one can conclude that the best derivative for enantiomeric separation of phosphine oxide 3 is the acidic Ca2+-salt of dibenzoyl-(2R,3R)-tartaric acid [Ca(H-DBTA)2; (R,R)-8] (Table 1, Entry 2). Changing the chiral scaffold from dibenzoyl-tartaric acid to di-p-toluoyl-tartaric acid, or using neutral salt instead of acidic salts did not lead to improved results (Compare Table 1, Entry 2 with Entries 3–5). In general, better enantiomeric separation of phosphine oxide 3 was obtained with acidic salts [(R,R)-8 or (R,R)-9] than with neutral salts [(R,R)-10 or (R,R)-11] (Compare Table 1, Entries 2 and 3 or Entries 4 and 5). Resolving agents Ca(H-DBTA)2 and Ca(H-DPTTA)2 [(R,R)-8 or (R,R)-9] contain Ca2+ and the corresponding tartaric acid derivative in a 1:2 ratio. Our previous studies revealed [57,58], that this stoichiometric ratio allows the formation of polymer-like catena structures, that stabilize the crystal structure of the diastereomer, and leads to improved enantiomeric separation of the given phosphine oxide coordinating to the Ca2+ ion.
The experimental results summarized in Table 1 indicated that the best ee and resolving capability (S) values can be obtained with Ca(H-DBTA)2 [(R,R)-8] prepared in situ. As the next step, we optimized solvents, solvent composition, amount of resolving agent (R,R)-8 and crystallization time applied for enantiomeric separation of phosphine oxide 3. Ca(H-DBTA)2 [(R,R)-8] was always prepared in situ, by refluxing (−)-O,O′-dibenzoyl-(2R,3R)-tartaric acid in a mixture of ethanol and water. Then the solution of ethyl-phenyl-propylphosphine oxide (3) was immediately added to the resolving agent [(R,R)-8]. The diastereomeric complex that precipitated from the solution upon cooling was crystallized for 24 h, and then it was separated from the mother liquor by filtration (Scheme 2). Enantiomeric mixture of phosphine oxide 3 could be liberated from the diastereomer by extraction with aqueous NH4OH and dichloromethane. Results are summarized in Table 2.
In the preliminary experiments (Table 1, Entries 1 and 2), coordination complexes were obtained with a composition of (3)∙Ca(H-DBTA)2. Thus, resolution of ethyl-phenyl-propylphosphine oxide (3) was first attempted using 0.5 equivalent of Ca(H-DBTA)2 [(R,R)-8] (i.e., according to half-equivalent method) (Table 2, Entries 1–9). Both components of the solvent mixture were changed systematically. It is noteworthy that resolving agent Ca(H-DBTA)2 [(R,R)-8] can only be prepared in an alcohol using a sufficient amount of water. Thus, Ca(H-DBTA)2 [(R,R)-8] was formed in situ in either methanol, ethanol or 2-propanol. Ethyl acetate, butyl acetate, ethanol, acetone, acetonitrile or toluene was the other solvent used for the dissolution of ethyl-phenyl-propylphosphine oxide (3). 1:1 Ratio of the two solvents was kept constant throughout the solvent optimization experiments (Table 2, Entries 1–9).
Results indicated that ethanol is the most suitable alcohol for the resolution investigated, as the use of methanol or 2-propanol led to lower yields or ee values of phosphine oxide 3 (Compare Table 2, Entry 1 with Entries 2 and 3). Considering the other component of the solvent mixture, the best results were obtained with ethyl acetate (Table 2, Entry 1). Using butyl acetate, resolving capability value showed parity to the ethyl acetate case, but the ee of 3 was lower (Compare Table 2, Entries 1 and 4). Both yield and ee of phosphine oxide 3 were significantly lower when acetone, acetonitrile or toluene was used as solvent (Table 2, Entries 5–7). Interestingly, the mixture of ethanol and ethyl acetate was necessary to obtain the best results, as lower ee and resolving capability values were obtained when ethanol or ethyl acetate was exclusively used for crystallization (Compare Table 2, Entry 1 with Entries 8 and 9). In the latter case, the resolution procedure was altered. Ethanol solution containing the in situ formed resolving agent [(R,R)-8] and racemic phosphine oxide 3 was evaporated to dryness, and the solid material was suspended in ethyl acetate.
The amount of resolving agent [(R,R)-8] and the composition of the solvent mixture were also optimized (Table 2, Entries 10–16). Results showed that optical resolution of ethyl-phenyl-propylphosphine oxide (3) is more efficient when 1 equivalent of Ca(H-DBTA)2 is used (i.e., according to equivalent method), which indicates that the separation of two diastereomeric species [(S)-3∙Ca(H-DBTA)2 and (R)-3∙Ca(H-DBTA)2] by crystallization is easier than the separation of (S)-3∙Ca(H-DBTA)2 diastereomer from the enantiomeric mixture containing (R)-3 in excess. Changing either concentration during crystallization (Table 2, Entries 11 and 12), or the ratio of ethanol and ethyl acetate in the solvent mixture (Table 2, Entries 13 and 14) did not lead to better ee and resolving capability values. Interestingly, the amount of water had a significant influence on the resolution efficiency. Throughout the optimization studies, water used was kept constant. When half amount of water was used, the yield of (S)-3∙Ca(H-DBTA)2 increased to 97% from 79%, but the de of the diastereomer dropped to 56% from 74%, giving an overall resolving capability value of 0.54, which is comparable to the original results (S = 0.54). In contrast, double amount of water in the solvent mixture led to the formation of no diastereomeric complexes but the precipitation of the resolving agent [(R,R)-8] (Compare Table 2, Entries 10, 15 and 16). The fact that the amount of strong H-bond donor and acceptor water had such a big influence of resolution efficiency indicates that H-bonds formed between the resolving agent [(R,R)-8] and phosphine oxide 3 may play a significant role in the formation of diastereomers, the crystallization process and consequently in enantiomeric recognition.
During the optimization studies, (S)-3∙Ca(H-DBTA)2 diastereomers were allowed to crystallize for 24 h. Two experiments were also conducted with 4 h or 72 h of crystallization time (see Supplementary Material for details). The results indicated that resolution of phosphine oxide 3 with Ca(H-DBTA)2 [(R,R)-8] is a thermodynamically controlled resolution, as no kinetic enhancement could be observed with a shortened crystallization time, and thermodynamic equilibrium can be reached after 24 h of crystallization and there is no point for extending the crystallization time.
Considering the results of the optimization studies (Table 1 and Table 2), the most efficient enantiomeric separation of phosphine oxide 3 could be obtained with Ca(H-DBTA)2 in a 1:1 mixture of ethyl acetate and ethanol, and (S)-3 could be obtained with an ee of 74% after the first crystallization. Different purification strategies of enantiomeric mixtures of (S)-ethyl-phenyl-propylphosphine oxide [(S)-3] were then evaluated, as it is also an integral part of every resolution procedure [59].
Three separate methods were tested, and the diastereomer of (S)-3∙Ca(H-DBTA)2 prepared with a de of 74% under optimal reaction conditions were used in these experiments. Crystals of (S)-3∙Ca(H-DBTA)2 were stirred at room temperature in a mixture of ethanol, ethyl acetate and water (digestion) (Scheme 3/II), or the diastereomer was recrystallized from the same solvent mixture (Scheme 3/III). The third purification method involved decomposition of (S)-3∙Ca(H-DBTA)2 diastereomeric complex, followed by repeated resolution of the enantiomeric mixture of (S)-ethyl-phenyl-propylphosphine oxide [(S)-3] with 1 equivalent of Ca(H-DBTA)2 [(R,R)-8] under optimal crystallization conditions (Scheme 3/IV and V). The results indicated that digestion was the least effective purification method, as de of (S)-3∙Ca(H-DBTA)2 diastereomer increased from 74% to 77%. Using either recrystallization or repeated resolution, diastereomeric purity reached 94% or 93%, respectively. Repeated resolution gave somewhat better yields (48% vs. 43%). As ethyl-phenyl-propylphosphine oxide (3) is an oily substrate at room temperature, the corresponding enantiomeric mixtures [(S)-3] could not be purified further by recrystallization without using any resolving agent or chiral additive.

3.2. Optical Resolution of Dialkyl-Arylphosphine Oxides (1, 2 and 4–7) with Ca(H-DBTA)2 [(R,R)-8] under Optimized Conditions

As the last step of this study, resolution of other dialkyl-arylphosphine oxides (1, 2 and 4–7) was also attempted with Ca(H-DBTA)2 [(R,R)-8] under optimal conditions. The resolving agent [(R,R)-8] was prepared in situ, a mixture of ethyl acetate, ethanol and water was used as solvent, crystallization time was 24h, and the enantiomeric mixtures of the corresponding phosphine oxides were purified by repeated resolution. In a few instances, the corresponding diastereomer was crystallized several times in order to reach high enantiomeric excess values. Resolutions were carried out according to the equivalent method (Scheme 4).
The results summarized in Table 3 show that the structure of phosphine oxide (1,2 and 4–7) had a significant influence on the efficiency of the resolution. (S)-Butyl-methyl-phenylphosphine oxide [(S)-4] could be prepared with a maximal ee of 96% after the second crystallization under optimized conditions, but yield of the corresponding phosphine oxide (S)-4, and consequently, efficiency of the resolution was rather low (Table 3, Entry 3). In order to increase the resolving capability values, resolution was carried out in half amount of solvent, and the diastereomer were crystallized three times. This change increased yield from 8% to 17%, and enantiomeric excess of (S)-4 reached also 96% after purifications (Table 3, Entry 4).
Four crystallizations were necessary, to obtain optically active ethyl-methyl-phenylphosphine-oxide [(R)-1] and methyl-phenyl-i-propylphosphine oxide [(R)-5] with an ee of 85% or 80%, respectively (Table 3, Entries 1 and 5). However, yield of the corresponding diastereomers was lower than 32%, thus no additional purifications were used in these instances. Interestingly, MePrPhP(O) (2) could not be resolved efficiently (ee 37%) (Table 3, Entry 2), despite the fact that this phosphine oxide was in close structural resemblance to other P-oxides used in this study.
c-Hexyl- and t-butyl-methyl-phenylphosphine oxides (6 and 7) could be resolved with the lowest efficiency, as no crystalline diastereomeric complexes were formed for phosphine oxide 6, whereas ee of the t-butyl-derivative (7) was only 3% (Table 3, Entry 6 and 7). These results indicated, that the increased steric demand cyclohexyl- or t-butyl-groups may hinder non-covalent interactions responsible for enantiomeric recognition, which leads to inefficient enantiomeric separation of these two phosphine oxides (6 and 7).
Interestingly, composition of the diastereomeric complex also varied in case of resolution of different phosphine oxide derivatives (1–7). Diastereomers incorporating the corresponding phosphine oxides and dibenzoyl-(2R,3R)-tartaric acid in a 1:2 ratio were obtained during the resolution of phosphine oxides 2–4 (Scheme 3; Table 3, Entries 2–4). However, this ratio changed to 1:1 or 3:4 when enanatiomeric separation of ethyl-, i-propyl- or t-butyl-methyl-phenylphosphine oxides (1, 5 and 7) was elaborated (Table 3, Entries 1, 5 and 7). This change in the composition of the diastereomers may indicate a change in second order interactions responsible for enantiomeric recognition.

4. Conclusions

In conclusion, this study demonstrated that the coordination mediated optical resolution method originally developed for cyclic phosphine oxides has a more general scope, and this technique can be used for acyclic phosphine oxides. Enantiomeric separation of a few dialkyl-phenylphosphine oxides (1–5 and 7) was elaborated with metals salts of tartaric acid derivatives. The resolution procedure, crystallization and purification conditions were optimized, and the most efficient enantioseparation was obtained with acidic Ca2+-salt (−)-O,O’-dibenzoyl-(2R,3R)-tartaric acid [(R,R)-8]. The (S) enantiomer ethyl-phenyl-propylphosphine oxide [(S)-3] and butyl-methyl-phenylphosphine oxide [(S)-4] was prepared with enantiomeric excess higher than 93%. On the other hand, enantiomeric mixtures of ethyl-, propyl and i-propyl-methyl-phenylphosphine oxide [(R)-1, (S)-2 and (R)-5] was obtained with ee being the range of 37–85%. Optical resolution of c-hexyl- and t-butyl-methyl-phenylphosphine oxides (6 and 7) was unsuccessful, likely due to the increased steric bulk of the branched alkyl groups.

Supplementary Materials

Details of chemicals, instruments used in this study, a few synthetic procedures, the characterization of the enantiomeric mixtures of phosphine oxides (1–7), as well as HPLC traced can be found in the Supplementary Material: https://www.mdpi.com/2073-8994/12/2/215/s1.

Author Contributions

Conceptualization, B.V. and P.B.; methodology, B.V.; validation, P.B.; formal analysis, B.V.; data curation, B.V.; writing—original draft preparation, B.V.; writing—review and editing, P.B.; visualization, B.V.; supervision, P.B.; project administration, P.B.; funding acquisition, P.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research, Development and Innovation Office—NKFIH (Grant No. OTKA PD 116096). Support of grant BME FIKP-BIO by Ministry of Human Capacities of Hungary (EMMI) is kindly acknowledged.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Börner, A. (Ed.) Phosphorus Ligands in Asymmetric Catalysis: Synthesis and Applications; Wiley-VCH: Weinheim, Germany, 2008. [Google Scholar]
  2. Grabulosa, A. P-Stereogenic Ligands in Enantioselective Catalysis; The Royal Society of Chemistry: Cambridge, UK, 2010. [Google Scholar]
  3. Dutartre, M.; Bayardon, J.; Jugé, S. Applications and stereoselective syntheses of P-chirogenic phosphorus compounds. Chem. Soc. Rev. 2016, 45, 5771–5794. [Google Scholar] [CrossRef]
  4. Kamer, P.C.J.; Van Leeuwen, P.W.N.M. (Eds.) Phosphorus(III)Ligands in Homogeneous Catalysis: Design and Synthesis; John Wiley & Sons: New York, NY, USA, 2012. [Google Scholar]
  5. Imamoto, T. Searching for practically useful P-chirogenic phosphine ligands. Chem. Rec. 2016, 16, 2655–2669. [Google Scholar] [CrossRef]
  6. Xiao, Y.; Sun, Z.; Guo, H.; Kwon, O. Chiral phosphines in nucleophilic organocatalysis. Beilstein J. Org. Chem. 2014, 10, 2089–2121. [Google Scholar] [CrossRef]
  7. Guo, H.; Fan, Y.C.; Sun, Z.; Wu, Y.; Kwon, O. Phosphine organocatalysis. Chem. Rev. 2018, 118, 10049–10293. [Google Scholar] [CrossRef]
  8. Ni, H.; Chan, W.-L.; Lu, Y. Phosphine-catalyzed asymmetric organic reactions. Chem. Rev. 2018, 118, 9344–9411. [Google Scholar] [CrossRef]
  9. Benaglia, M.; Rossi, S. Chiral phosphine oxides in present-day organocatalysis. Org. Biomol. Chem. 2010, 8, 3824–3830. [Google Scholar] [CrossRef]
  10. Ayad, T.; Gernet, A.; Pirat, J.-L.; Virieux, D. Enantioselective reactions catalyzed by phosphine oxides. Tetrahedron 2019, 75, 4385–4418. [Google Scholar] [CrossRef]
  11. Liu, S.; Kumatabara, Y.; Shirakawa, S. Chiral quaternary phosphonium salts as phase-transfer catalysts for environmentally benign asymmetric transformations. Green Chem. 2016, 18, 331–341. [Google Scholar] [CrossRef]
  12. Golandaj, A.; Ahmad, A.; Ramjugernath, D. Phosphonium salts in asymmetric catalysis: A journey in a decade’s extensive research work. Adv. Synth. Catal. 2017, 359, 3676–3706. [Google Scholar] [CrossRef]
  13. Knowles, W.S. Asymmetric Hydrogenations (Nobel Lecture). Angew. Chem. Int. Ed. 2002, 41, 1998–2007. [Google Scholar] [CrossRef]
  14. Beaud, R.; Phipps, R.J.; Gaunt, M.J. Enantioselective Cu-catalyzed arylation of secondary phosphine oxides with diaryliodonium salts toward the synthesis of P-chiral phosphines. J. Am. Chem. Soc. 2016, 138, 13183–13186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Liu, X.-T.; Zhang, Y.-Q.; Han, X.-Y.; Sun, S.-P.; Zhang, Q.-W. Ni-Catalyzed asymmetric allylation of secondary phosphine oxides. J. Am. Chem. Soc. 2019, 141, 16584–16589. [Google Scholar] [CrossRef] [PubMed]
  16. Korpiun, O.; Lewis, R.A.; Chickos, J.; Mislow, K. Synthesis and absolute configuration of optically active phosphine oxides and phosphinates. J. Am. Chem. Soc. 1968, 90, 4842–4846. [Google Scholar] [CrossRef]
  17. Andersen, N.G.; Ramsden, P.D.; Che, D.Q.; Parvez, M.; Keay, B.A. A simple resolution procedure using the Staudinger reaction for the preparation of P-stereogenic phosphine oxides. J. Org. Chem. 2001, 66, 7478–7486. [Google Scholar] [CrossRef]
  18. Oliana, M.; King, F.; Horton, P.N.; Hursthouse, M.B.; Hii, K.K. Practical synthesis of chiral vinylphosphine oxides by direct nucleophilic substitution. Stereodivergent synthesis of aminophosphine ligands. J. Org. Chem. 2006, 71, 2472–2479. [Google Scholar] [CrossRef]
  19. Adams, H.; Collins, R.C.; Jones, S.; Warner, C.J.A. Enantioselective preparation of P-chiral phosphine oxides. Org. Lett. 2011, 13, 6576–6579. [Google Scholar] [CrossRef]
  20. Chaux, F.; Frynas, S.; Laureano, H.; Salomon, C.; Morata, G.; Auclair, M.-L.; (Massoud) Stephan, M.; Merdès, R.; Richard, P.; Ondel-Eymin, M.-J.; et al. Enantiodivergent synthesis of P-chirogenic phosphines. C. R. Chim. 2010, 13, 1213–1226. [Google Scholar] [CrossRef]
  21. Han, Z.S.; Goyal, N.; Herbage, M.A.; Sieber, J.D.; Qu, B.; Xu, Y.; Li, Z.; Reeves, J.T.; Desrosiers, J.-N.; Ma, S.; et al. Efficient asymmetric synthesis of P-chiral phosphine oxides via properly designed and activated benzoxazaphosphinine-2-oxide agents. J. Am. Chem. Soc. 2013, 135, 2474–2477. [Google Scholar] [CrossRef]
  22. Copey, L.; Jean-Gérard, L.; Framery, E.; Pilet, G.; Robert, V.; Andrioletti, B. Experimental and theoretical investigations of the stereoselective synthesis of P-stereogenic phosphine oxides. Chem. Eur. J. 2015, 21, 9057–9061. [Google Scholar] [CrossRef]
  23. D’Onofrio, A.; Copey, L.; Jean-Gérard, L.; Goux-Henry, C.; Pilet, G.; Andrioletti, B.; Framery, E. D-Glucosamine as a novel chiral auxiliary for the stereoselective synthesis of P-stereogenic phosphine oxides. Org. Biomol. Chem. 2015, 13, 9029–9034. [Google Scholar] [CrossRef]
  24. Li, S.-G.; Yuan, M.; Topic, F.; Han, Z.S.; Senanayake, C.H.; Tsantrizos, Y.S. Asymmetric library synthesis of P-chiral t-butyl-substituted secondary and tertiary phosphine oxides. J. Org. Chem. 2019, 84, 7291–7302. [Google Scholar] [CrossRef] [PubMed]
  25. Haynes, R.K.; Au-Yeung, T.-L.; Chan, W.-K.; Lam, W.-L.; Li, Z.-Y.; Yeung, L.-L.; Chan, A.S.C.; Li, P.; Koen, M.; Mitchell, C.R.; et al. Reaction of metallated tert-butyl(phenyl)phosphane oxide with electrophiles as a route to functionalized tertiary phosphane oxides: Alkylation reactions. Eur. J. Org. Chem. 2000, 2000, 3205–3216. [Google Scholar] [CrossRef]
  26. Xu, Q.; Zhao, C.-Q.; Han, L.-B. Stereospecific nucleophilic substitution of optically pure H-phosphinates: A general way for the preparation of chiral P-stereogenic phosphine oxides. J. Am. Chem. Soc. 2008, 130, 12648–12655. [Google Scholar] [CrossRef] [PubMed]
  27. Han, Z.S.; Wu, H.; Xu, Y.; Zhang, Y.; Qu, B.; Li, Z.; Caldwell, D.R.; Fandrick, K.R.; Zhang, L.; Roschangar, F.; et al. General and stereoselective method for the synthesis of sterically congested and structurally diverse P-stereogenic secondary phosphine oxides. Org. Lett. 2017, 19, 1796–1799. [Google Scholar] [CrossRef] [PubMed]
  28. Chrzanowski, J.; Krasowska, D.; Urbaniak, M.; Sieroń, L.; Pokora-Sobczak, P.; Demchuk, O.M.; Drabowicz, J. Synthesis of enantioenriched aryl-tert-butylphenylphosphine oxides via cross-coupling reactions of tert -butylphenylphosphine oxide with aryl halides. Eur. J. Org. Chem. 2018, 2018, 4614–4627. [Google Scholar] [CrossRef]
  29. Kiełbasiński, P.; Źurawiński, R.; Pietrusiewicz, K.M.; Zabłocka, M.; Mikołajczyk, M. Enzymatic resolution of racemic phosphinoylacetates having a stereogenic phosphorus atom. Tetrahedron Lett. 1994, 35, 7081–7084. [Google Scholar] [CrossRef]
  30. Kaczmarczyk, S.; Kwiatkowska, M.; Madalińska, L.; Barbachowska, A.; Rachwalski, M.; Błaszczyk, J.; Sieroń, L.; Kiełbasiński, P. Enzymatic synthesis of enantiopure precursors of chiral bidentate and tridentate phosphorus catalysts. Adv. Synth. Catal. 2011, 353, 2446–2454. [Google Scholar] [CrossRef]
  31. Shioji, K.; Ueno, Y.; Kurauchi, Y.; Okuma, K. Lipase-catalyzed kinetic resolution of P-chiral phosphorus compounds: Enantiopreference of Pseudomonas lipase and Candida antarctica lipase. Tetrahedron Lett. 2001, 42, 6569–6571. [Google Scholar] [CrossRef]
  32. Zhang, Y.; He, H.; Wang, Q.; Cai, Q. Asymmetric synthesis of chiral P-stereogenic triaryl phosphine oxides via Pd-catalyzed kinetic arylation of diaryl phosphine oxides. Tetrahedron Lett. 2016, 57, 5308–5311. [Google Scholar] [CrossRef]
  33. Fernández-Pérez, H.; Vidal-Ferran, A. Stereoselective catalytic synthesis of P-stereogenic oxides via hydrogenative kinetic resolution. Org. Lett. 2019, 21, 7019–7023. [Google Scholar] [CrossRef]
  34. Bergin, E.; O’Connor, C.T.; Robinson, S.B.; McGarrigle, E.M.; O’Mahony, C.P.; Gilheany, D.G. Synthesis of P-stereogenic phosphorus compounds. Asymmetric oxidation of phosphines under Appel conditions. J. Am. Chem. Soc. 2007, 129, 9566–9567. [Google Scholar] [CrossRef]
  35. Nikitin, K.; Rajendran, K.V.; Müller-Bunz, H.; Gilheany, D.G. Turning regioselectivity into stereoselectivity: Efficient dual resolution of P-stereogenic phosphine oxides through bifurcation of the reaction pathway of a common intermediate. Angew. Chem. Int. Ed. 2014, 53, 1906–1909. [Google Scholar] [CrossRef] [PubMed]
  36. Rajendran, K.V.; Nikitin, K.V.; Gilheany, D.G. Hammond postulate mirroring enables enantiomeric enrichment of phosphorus compounds via two thermodynamically interconnected sequential stereoselective processes. J. Am. Chem. Soc. 2015, 137, 9375–9381. [Google Scholar] [CrossRef] [PubMed]
  37. Kortmann, F.A.; Chang, M.-C.; Otten, E.; Couzijn, E.P.A.; Lutz, M.; Minnaard, A.J. Consecutive dynamic resolutions of phosphine oxides. Chem. Sci. 2014, 5, 1322–1327. [Google Scholar] [CrossRef] [Green Version]
  38. Ironmonger, A.; Shipton, M.; Slater, F.; Szeto, P.; Unthank, M.G.; Alexandre, F.R.; Caillet, C.; Dousson, C.B. A highly diastereoselective chloride-mediated dynamic kinetic resolution at phosphorus on-route to a key intermediate in the synthesis of GSK2248761A. Tetrahedron Lett. 2018, 59, 2154–2156. [Google Scholar] [CrossRef]
  39. Jiang, X.; Minnaard, A.J.; Hessen, B.; Feringa, B.L.; Duchateau, A.L.L.; Andrien, J.G.O.; Boogers, J.A.F.; de Vries, J.G. Application of monodentate secondary phosphine oxides, a new class of chiral ligands, in Ir(I)-catalyzed asymmetric imine hydrogenation. Org. Lett. 2003, 5, 1503–1506. [Google Scholar] [CrossRef]
  40. Gatineau, D.; Nguyen, D.H.; Hérault, D.; Vanthuyne, N.; Leclaire, J.; Giordano, L.; Buono, G. H-adamantylphosphinates as universal precursors of P-stereogenic compounds. J. Org. Chem. 2015, 80, 4132–4141. [Google Scholar] [CrossRef]
  41. Toda, F.; Mori, K.; Stein, Z.; Goldberg, I. Optical resolution of phosphinates and phosphine oxides by complex formation with optically active 2,2’-dihydroxy-1,1’-binaphthyl and crystallographic study of two diastereomeric complexes with methyl methylphenylphosphinate. J. Org. Chem. 1988, 53, 308–312. [Google Scholar] [CrossRef]
  42. Drabowicz, J.; Łyżwa, P.; Omelańczuk, J.; Pietrusiewicz, K.M.; Mikołajczyk, M. New procedures for the resolution of chiral tert-butylphenylphosphine oxide and some of its reactions. Tetrahedron Asymmetry 1999, 10, 2757–2763. [Google Scholar] [CrossRef]
  43. Holt, J.; Maj, A.M.; Schudde, E.P.; Pietrusiewicz, K.M.; Sieroń, L.; Wieczorek, W.; Jerphagnon, T.; Arends, I.W.C.E.; Hanefeld, U.; Minnaard, A.J. On the resolution of secondary phosphine oxides via diastereomeric complex formation: The case of tert-butylphenylphosphine oxide. Synthesis 2009, 2009, 2061–2065. [Google Scholar]
  44. Bagi, P.; Ujj, V.; Czugler, M.; Fogassy, E.; Keglevich, G. Resolution of P-stereogenic P-heterocycles via the formation of diastereomeric molecular and coordination complexes (a review). Dalton Trans. 2016, 45, 1823–1842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Bagi, P.; Varga, B.; Szilágyi, A.; Karaghiosoff, K.; Czugler, M.; Fogassy, E.; Keglevich, G. The resolution of acyclic P-stereogenic phosphine oxides via the formation of diastereomeric complexes: A case study on ethyl-(2-methylphenyl)-phenylphosphine oxide. Chirality 2018, 30, 509–522. [Google Scholar] [CrossRef] [PubMed]
  46. Dziuba, K.; Lubańska, M.; Pietrusiewicz, K.M. Enantiodivergent synthesis of both PAMPO enantiomers using l-menthyl chloroacetate and stereomutation at P in classical quaternisation reactions. Synthesis 2019. Available online: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1691531 (accessed on 14 January 2020). [CrossRef]
  47. Faigl, F.; Fogassy, E.; Nógrádi, M.; Pálovics, E.; Schindler, J. Strategies in optical resolution: A practical guide. Tetrahedron Asymmetry 2008, 19, 519–536. [Google Scholar] [CrossRef]
  48. Mane, S. Racemic drug resolution: A comprehensive guide. Anal. Methods 2016, 8, 7567–7586. [Google Scholar] [CrossRef]
  49. Bagi, P.; Herbay, R. Resolution of phosphine oxides. In Organophosphorus Chemistry—Novel Developments; Keglevich, G., Ed.; De Gruyter: Berlin, Germany, 2018; pp. 66–90. [Google Scholar]
  50. Meisenheimer, J.; Casper, J.; Höring, M.; Lauter, W.; Lichtenstadt, L.; Samuel, W. Optisch-aktive Phosphinoxyde. J. Liebig. Ann. Chem. 1926, 449, 213–248. [Google Scholar] [CrossRef]
  51. Kozma, D.; Bocskei, Z.; Kassai, C.; Simon, K.; Fogassy, E. Optical resolution of racemic alcohols by diastereoisomeric complex formation with O,O’-dibenzoyl-(2R,3R)-tartaric acid; the crystal structure of the (-)-(1R,2S,5R)-menthol-O,O’-dibenzoyl-(2R,3R)-tartaric acid complex. Chem. Commun. 1996, 635, 753–754. [Google Scholar] [CrossRef]
  52. Mravik, A.; Böcskei, Z.; Katona, Z.; Markovits, I.; Fogassy, E. Coordination-mediated optical resolution of carboxylic acids with O,O′-dibenzoyltartaric acid. Angew. Chem. Int. Ed. 1997, 36, 1534–1536. [Google Scholar] [CrossRef]
  53. Xu, H.; Wang, Q.; Zhu, J.; Deng, J.; Cun, L.; Cui, X.; Wu, J.; Xu, X.; Wu, Y. Copper(II)-mediated resolution of alpha-halo carboxylic acids with chiral O,O’-dibenzoyltartaric acid: Spontaneous racemization and crystallization-induced dynamic resolution. Org. Biomol. Chem. 2005, 3, 4227–4232. [Google Scholar] [CrossRef]
  54. Degenbeck, H.; Felten, A.S.; Etxebarria, J.; Escudero-Adán, E.C.; Benet-Buchholz, J.; Vidal-Ferran, A. Crystallization-induced dynamic resolution of stereolabile biaryl derivatives involving supramolecular interactions. Cryst. Growth Des. 2012, 12, 2719–2723. [Google Scholar] [CrossRef]
  55. Hu, Y.; Wu, C.; Wu, X.Y.; Li, S.L.; Sun, X.X.; Tang, Z.B. Efficient preparation of (R)-2-chloromandelic acid via a recycle process of resolution. Chirality 2015, 27, 281–285. [Google Scholar] [CrossRef]
  56. Yang, B.; Xie, H.; Ran, K.; Gan, Y. Efficient synthesis and resolution of Tenofovir Alafenamide. Lett. Org. Chem. 2017, 15, 10–14. [Google Scholar] [CrossRef]
  57. Ujj, V.; Schindler, J.; Novák, T.; Czugler, M.; Fogassy, E.; Keglevich, G. Coordinative resolution of 1-phenyl- and 1-naphthyl-3-methyl-3-phospholene 1-oxides with calcium hydrogen O,O′-dibenzoyl-(2R,3R)-tartrate or calcium hydrogen O,O′-di-p-toluyl-(2R,3R)-tartrate. Tetrahedron Asymmetry 2008, 19, 1973–1977. [Google Scholar] [CrossRef]
  58. Bagi, P.; Karaghiosoff, K.; Czugler, M.; Hessz, D.; Kállay, M.; Kubinyi, M.; Szilvási, T.; Pongrácz, P.; Kollár, L.; Timári, I.; et al. Synthesis, characterization, and application of platinum(II) complexes incorporating racemic and optically active 4-chloro-5-methyl-1-phenyl-1,2,3,6-tetrahydrophosphinine ligand. Heteroatom. Chem. 2016, 27, 91–101. [Google Scholar] [CrossRef] [Green Version]
  59. Faigl, F.; Fogassy, E.; Nógrádi, M.; Pálovics, E.; Schindler, J. Separation of non-racemic mixtures of enantiomers: An essential part of optical resolution. Org. Biomol. Chem. 2010, 8, 947–959. [Google Scholar] [CrossRef]
Symmetry 12 00215 g001 550
Figure 1. Racemic dialkyl-arylphosphine oxides (1–7) and resolving agents [(R,R)-8–[(R,R)-11] used in this study.
Figure 1. Racemic dialkyl-arylphosphine oxides (1–7) and resolving agents [(R,R)-8–[(R,R)-11] used in this study.
Symmetry 12 00215 g001
Symmetry 12 00215 sch001 550
Scheme 1. Optical resolution of ethyl-phenyl-propylphosphine oxide (3) with different Ca2+ salts of tartaric-acid derivatives [(R,R)-8–(R,R)-11].
Scheme 1. Optical resolution of ethyl-phenyl-propylphosphine oxide (3) with different Ca2+ salts of tartaric-acid derivatives [(R,R)-8–(R,R)-11].
Symmetry 12 00215 sch001
Symmetry 12 00215 sch002 550
Scheme 2. Optimization of crystallization conditions for resolution of ethyl-phenyl-propylphosphine oxide (3) with Ca(H-DBTA)2 [(R,R)-8] prepared in situ.
Scheme 2. Optimization of crystallization conditions for resolution of ethyl-phenyl-propylphosphine oxide (3) with Ca(H-DBTA)2 [(R,R)-8] prepared in situ.
Symmetry 12 00215 sch002
Symmetry 12 00215 sch003 550
Scheme 3. Purification possibilities of enantiomeric mixtures of (S)-ethyl-phenyl-propylphosphine oxide [(S)-3].
Scheme 3. Purification possibilities of enantiomeric mixtures of (S)-ethyl-phenyl-propylphosphine oxide [(S)-3].
Symmetry 12 00215 sch003
Symmetry 12 00215 sch004 550
Scheme 4. Optical resolution of dialkyl-arylphosphine oxides (1, 2 and 4–7) with Ca(H-DBTA)2 [(R,R)-8] under optimized conditions.
Scheme 4. Optical resolution of dialkyl-arylphosphine oxides (1, 2 and 4–7) with Ca(H-DBTA)2 [(R,R)-8] under optimized conditions.
Symmetry 12 00215 sch004
Table
Table 1. Optical resolution of ethyl-phenyl-propylphosphine oxide (3) with different Ca2+ salts of tartaric-acid derivatives [(R,R)-8–(R,R)-11].
Table 1. Optical resolution of ethyl-phenyl-propylphosphine oxide (3) with different Ca2+ salts of tartaric-acid derivatives [(R,R)-8–(R,R)-11].
Entry Resolving AgentEq.Solvents aDiastereomeric
Complex b		Yield c,g
(%)		Eed,g
(%)		S e,g
(-)		Abs. Config. f
1 hCa(H-DBTA)20.53 × EtOAc/3 × EtOH(3)∙Ca(H-DBTA)283440.36(S)
2 iCa(H-DBTA)20.53 × EtOAc/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)262690.43(S)
3 iCa(DBTA)0.53 × EtOAc/3 × EtOH/0.3 × H2O(3)∙Ca(DBTA)115190.22(S)
4 iCa(H-DPTTA)20.53 × EtOAc/3 × EtOH/0.3 × H2O(3)∙Ca(H-DPTTA)266380.25(S)
5 iCa(DPTTA)0.53 × EtOAc/3 × EtOH/0.3 × H2Ono complex----
a Mixture of solvents for crystallization and recrystallizations [mL of solvent/g of resolving agent]. b Ratio of phosphine oxide and resolving agent was determined by 1H NMR. c Yield of the diastereomer was calculated based on half of the racemic phosphine oxide that is regarded to be 100% for each antipode. d Determined by HPLC using a chiral stationary phase. e Resolving capability, also known as the Fogassy parameter [S (-) = (Yield [%]/100)×(ee [%]/100)]. f Absolute configuration of phosphine oxides was determined by comparing specific rotation with literature data. g Results obtained after first crystallization are shown. The diastereomeric complexes were not purified. h Resolution is carried out using pre-made resolving agent. i Resolution is carried out using in situ prepared resolving agent.
Table
Table 2. Optimization of crystallization conditions for the resolution of ethyl-phenyl-propylphosphine oxide (3) with Ca(H-DBTA)2 [(R,R)-8] prepared in situ.
Table 2. Optimization of crystallization conditions for the resolution of ethyl-phenyl-propylphosphine oxide (3) with Ca(H-DBTA)2 [(R,R)-8] prepared in situ.
Entry Eq. of Ca(H-DBTA)2Solvents aDiastereomeric Complex bYield c,g (%)Eed,g (%)S e,g(-)Abs. Config. f
1 h0.53 × EtOAc/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)262690.43(S)
20.53 × EtOAc/3 × MeOH/0.3 × H2O(3)∙Ca(H-DBTA)218790.14(S)
30.53 × EtOAc/3 × 2-PrOH/0.3 × H2O(3)∙Ca(H-DBTA)266170.11(S)
40.53 × BuOAc/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)270550.38(S)
50.53 × acetone/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)262140.08(S)
60.53 × MeCN/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)242180.06(S)
70.53 × toluene/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)22700.00(S)
80.56 × EtOH/0.3 × H2O(3)4∙Ca3(H-DBTA)675440.33(S)
90.56 × EtOAc(3)2∙Ca(H-DBTA)2123120.15(S)
1013 × EtOAc/3 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)279740.58(S)
1111.5 × EtOAc/1.5 × EtOH/0.15 × H2O(3)∙Ca(H-DBTA)2105540.57(S)
1214.5 × EtOAc/4.5 × EtOH/0.45 × H2O(3)∙Ca(H-DBTA)265730.48(S)
1315 × EtOAc/1 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)2132390.50(S)
1411 × EtOAc/5 × EtOH/0.3 × H2O(3)∙Ca(H-DBTA)257710.41(S)
1513 × EtOAc/3 × EtOH/0.15 × H2O(3)∙Ca(H-DBTA)297560.54(S)
1613 × EtOAc/3 × EtOH/0.6 × H2OCa(H-DBTA)2----
a–g See Table 1 for footnotes. h Table 1, Entry 2.
Table
Table 3. Optical resolution of dialkyl-arylphosphine oxides (1, 2 and 4–7) with Ca(H-DBTA)2 [(R,R)-8] under optimized conditions.
Table 3. Optical resolution of dialkyl-arylphosphine oxides (1, 2 and 4–7) with Ca(H-DBTA)2 [(R,R)-8] under optimized conditions.
Entry R1 = Me, R2 =Diastereomeric Complex aNumber of CrystallizationsYield b (%)Eec (%)S d (-)Abs. Config. e
1Et (1)(1)2∙Ca(H-DBTA)2I.109340.37(R)
II.73660.48
III.46800.36
IV.32850.27
2Pr (2)(2)∙Ca(H-DBTA)2I.16370.06(S)
3Bu (4)(4)∙Ca(H-DBTA)2I.26750.20(S)
II.8960.08
4 fBu (4)(4)∙Ca(H-DBTA)2I.69540.37(S)
II.34860.29
III.17960.16
5i-Pr (5)(5)3∙Ca2(H-DBTA)4I.91320.29(R)
II.54530.29
III.30690.21
IV.20800.16
6c-Hex (6)no complex-----
7t-Bu (7)(7)2∙Ca(H-DBTA)2I.12530.04(R)
II.7930.03
a Ratio of phosphine oxides (1, 2, 4–7) and resolving agent was determined by 1 H NMR. b Yield of the diastereomer was calculated based on half of the racemic phosphine oxides (1, 2, 4–7) that is regarded to be 100% for each antipode. c Determined by HPLC using a chiral stationary phase. d Resolving capability, also known as the Fogassy parameter [S (-) = (Yield [%] /100) × (ee [%]/100)]. e Absolute configuration of phosphine oxides (1, 2, 4–7) was determined by specific rotation. f Resolution and the purification were carried out using half amount of solvents.

Share and Cite

MDPI and ACS Style

Varga, B.; Bagi, P. Preparation of Enantiomerically Enriched P-Stereogenic Dialkyl-Arylphosphine Oxides via Coordination Mediated Optical Resolution. Symmetry 2020, 12, 215. https://doi.org/10.3390/sym12020215

AMA Style

Varga B, Bagi P. Preparation of Enantiomerically Enriched P-Stereogenic Dialkyl-Arylphosphine Oxides via Coordination Mediated Optical Resolution. Symmetry. 2020; 12(2):215. https://doi.org/10.3390/sym12020215

Chicago/Turabian Style

Varga, Bence, and Péter Bagi. 2020. "Preparation of Enantiomerically Enriched P-Stereogenic Dialkyl-Arylphosphine Oxides via Coordination Mediated Optical Resolution" Symmetry 12, no. 2: 215. https://doi.org/10.3390/sym12020215

APA Style

Varga, B., & Bagi, P. (2020). Preparation of Enantiomerically Enriched P-Stereogenic Dialkyl-Arylphosphine Oxides via Coordination Mediated Optical Resolution. Symmetry, 12(2), 215. https://doi.org/10.3390/sym12020215

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop